Recombinant multi-species CHD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CHD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2810013C04Rik,2810040A01Rik,5630401D06Rik,ATP-dependent helicase CHD2,CHD-2,CHD2,Chd2,Chromodomain-helicase-DNA-binding protein 2,DEE94,EEOC

Target products collectionGo to CHD2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3928-Ag-1/ GM-Tg-hg-IP3928-Ag-2 Human CHD2 protein Human
GM-Tg-rg-IP3928-Ag-1/ GM-Tg-rg-IP3928-Ag-2 Rat CHD2 protein Rat
GM-Tg-mg-IP3928-Ag-1/ GM-Tg-mg-IP3928-Ag-2 Mouse CHD2 protein Mouse
GM-Tg-cynog-IP3928-Ag-1/ GM-Tg-cynog-IP3928-Ag-2 Cynomolgus/Rhesus macaque CHD2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3928-Ag-1/ GM-Tg-felg-IP3928-Ag-2 Feline CHD2 protein Feline
GM-Tg-cang-IP3928-Ag-1/ GM-Tg-cang-IP3928-Ag-2 Canine CHD2 protein Canine
GM-Tg-bovg-IP3928-Ag-1/ GM-Tg-bovg-IP3928-Ag-2 Bovine CHD2 protein Bovine
GM-Tg-equg-IP3928-Ag-1/ GM-Tg-equg-IP3928-Ag-2 Equine CHD2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3928-Ag-1/ GM-Tg-hg-IP3928-Ag-2; GM-Tg-rg-IP3928-Ag-1/ GM-Tg-rg-IP3928-Ag-2;
GM-Tg-mg-IP3928-Ag-1/ GM-Tg-mg-IP3928-Ag-2; GM-Tg-cynog-IP3928-Ag-1/ GM-Tg-cynog-IP3928-Ag-2;
GM-Tg-felg-IP3928-Ag-1/ GM-Tg-felg-IP3928-Ag-2; GM-Tg-cang-IP3928-Ag-1/ GM-Tg-cang-IP3928-Ag-2;
GM-Tg-bovg-IP3928-Ag-1/ GM-Tg-bovg-IP3928-Ag-2; GM-Tg-equg-IP3928-Ag-1/ GM-Tg-equg-IP3928-Ag-2
Products Name CHD2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CHD2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CHD2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.